Research and Development

UK-headquartered biotech Silence Therapeutics has appointed Thomas Christély as chief executive. He was instrumental in the merger of Silence Therapeutics …

A new version of the MHRA pharmacovigilance Compliance Report (Good Pharmacovigilance Practice Questionnaire) has been released by the MHRA.Submission of …

Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …

Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …

It usually starts with a subtle change of colour or shape in an existing mole. But if left undiagnosed and …

GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …

Research paid for by the UK taxpayer must be made more accessible to the public, researchers and other stake holders, …

Researchers in the US and West Africa believe they have identified the first effective blood-stage malaria vaccine, a development which …

A few years ago I was dealing with a big CRO which had been commissioned to run a pharmacokinetics (PK) …

The European Commission has granted the first ever children’s medicine to hold a new Paediatric Use Marketing Authorisation (PUMA). The …

Scientists from Merck & Co and China-based genomics specialist BGI are to work together to find and develop biomarkers and …

The FDA has unveiled a reorganisation of how it reviews new cancer drugs, and says the new approach should help …

GlaxoSmithKline and Amicus Therapeutics are moving forward with their phase III programme for Fabry disease treatment Amigal. The first patient …

Novartis’ global head of development Trevor Mundel is to leave the company and take a senior position at The Bill …

The recast Directive on the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU) will …